These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36192239)

  • 1. For novel cardiovascular therapy discovery and development.
    Madukwe JC
    Trends Pharmacol Sci; 2022 Nov; 43(11):885-887. PubMed ID: 36192239
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of drug discovery for treatment of cardiovascular diseases.
    Kennedy C
    Future Med Chem; 2013 Mar; 5(4):355-7. PubMed ID: 23495678
    [No Abstract]   [Full Text] [Related]  

  • 3. The Future of Cardiovascular Therapeutics.
    MacRae CA; Roden DM; Loscalzo J
    Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
    [No Abstract]   [Full Text] [Related]  

  • 4. Chinese innovation in cardiovascular drug discovery.
    Wang X; Ji Y; Yang B
    Br J Pharmacol; 2015 Dec; 172(23):5425-9. PubMed ID: 26629875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular pipeline decline quantified.
    Mullard A
    Nat Rev Drug Discov; 2016 Sep; 15(10):669. PubMed ID: 27681785
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges in the Development of Novel Cardiovascular Therapies.
    Hwang TJ; Kesselheim AS
    Clin Pharmacol Ther; 2017 Aug; 102(2):194-196. PubMed ID: 28643861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacology in the post-blockbuster era.
    Brandes RP
    Curr Opin Pharmacol; 2010 Apr; 10(2):109-10. PubMed ID: 20202904
    [No Abstract]   [Full Text] [Related]  

  • 8. Abstracts of the 11th International Congress on Cardiovascular Pharmacotherapy. Montreal, Canada, 18-21 May 2002.
    Cardiovasc Drugs Ther; 2002; 16 Suppl 1():5-116. PubMed ID: 12108434
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular and Hematological Medicine in 2015--Advances and Insights.
    Mukherjee D
    Cardiovasc Hematol Agents Med Chem; 2015; 13(1):1. PubMed ID: 26468555
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular-Active Venom Toxins: An Overview.
    Rebello Horta CC; Chatzaki M; Rezende BA; Magalhães Bde F; Duarte CG; Felicori LF; Ribeiro Oliveira-Mendes BB; do Carmo AO; Chávez-Olórtegui C; Kalapothakis E
    Curr Med Chem; 2016; 23(6):603-22. PubMed ID: 26812904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occlusion in the Flow of New Drugs for Cardiovascular Disease.
    Ringel MS; Shah NA; Baedeker M; Lim CT; Lamichhane A; Schulze U
    Clin Pharmacol Ther; 2017 Aug; 102(2):246-253. PubMed ID: 28378877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organs-on-chip models for cardiovascular drug development.
    Zimmermann WH
    Cardiovasc Res; 2021 Nov; 117(12):e164-e165. PubMed ID: 34347045
    [No Abstract]   [Full Text] [Related]  

  • 13. Abstracts of the 13th International Congress on Cardiovascular Pharmacotherapy. November 29-December 2, 2007. Antalya, Turkey.
    Remme WJ
    Cardiovasc Drugs Ther; 2007 Nov; 21 Suppl 1(1):S6-43. PubMed ID: 17963033
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular and Hematological Medicine in 2019 - Advances and Insights.
    Mukherjee D
    Cardiovasc Hematol Agents Med Chem; 2019; 17(1):2. PubMed ID: 31556359
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomics to Revive Drug Development in Cardiovascular Disease.
    Dubé MP; de Denus S; Tardif JC
    Cardiovasc Drugs Ther; 2016 Feb; 30(1):59-64. PubMed ID: 26768480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular research is thriving in China.
    Gao F; Sun RJ; Ji Y; Yang BF
    Br J Pharmacol; 2015 Dec; 172(23):5430-4. PubMed ID: 24962428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Navigating the Future of Cardiovascular Drug Development-Leveraging Novel Approaches to Drive Innovation and Drug Discovery: Summary of Findings from the Novel Cardiovascular Therapeutics Conference.
    Povsic TJ; Scott R; Mahaffey KW; Blaustein R; Edelberg JM; Lefkowitz MP; Solomon SD; Fox JC; Healy KE; Khakoo AY; Losordo DW; Malik FI; Monia BP; Montgomery RL; Riesmeyer J; Schwartz GG; Zelenkofske SL; Wu JC; Wasserman SM; Roe MT
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):445-458. PubMed ID: 28735360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro diagnostics in the development and use of cardiovascular medicines.
    Leadley RJ
    Curr Opin Mol Ther; 2010 Dec; 12(6):639-46. PubMed ID: 21154155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine phosphorylase: A potential new target for treating cardiovascular disease.
    Li W; Yue H
    Trends Cardiovasc Med; 2018 Apr; 28(3):157-171. PubMed ID: 29108898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Discovery and Development of Marine Natural Products with Cardiovascular Pharmacological Effects.
    Zhou JB; Luo R; Zheng YL; Pang JY
    Mini Rev Med Chem; 2018; 18(6):527-550. PubMed ID: 28969542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.